C677T methylenetetrahydrofolate reductase gene polymorphisms in bipolar disorder: An association study in the Chinese population and a meta-analysis of genetic association studies

Neuroscience Letters

Volumn 449, Issue 1, 2009, Pages 48-51

  Chen, Zhuo ^a   Liu, Yun ^a   Zhang, Di ^a   Liu, Zhe ^a   Wang, Peng ^c   Zhou, Daizhan ^a   Zhao, Teng ^a   Wang, Ting ^a   Xu, He ^a,b   Li, Sheng ^a,b   Feng, Guoyin ^d   He, Lin ^a,b,e   Yu, Lan ^a,b  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c The Fourth People's Hospital of Wuhu   (China)

^d SHANGHAI MENTAL HEALTH CENTER   (China)

^e FUDAN UNIVERSITY   (China)

Author keywords

Bipolar; Folate; Methylation; MTHFR

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ARTICLE; BIPOLAR DISORDER; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BIPOLAR DISORDER; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; META-ANALYSIS AS TOPIC; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 56449126373     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.10.077     Document Type: Article

References (30)

1. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls, Nature 447 (2007), pp. 661-678.
2. Abdolmaleky H.M., Thiagalingam S., and Wilcox M. Genetics and epigenetics in major psychiatric disorders: dilemmas, achievements, applications, and future scope. Am. J. Pharmacogenomics 5 (2005) 149-160
3. Althoff R.R., Faraone S.V., Rettew D.C., Morley C.P., and Hudziak J.J. Family, twin, adoption, and molecular genetic studies of juvenile bipolar disorder. Bipolar Disord. 7 (2005) 598-609
4. Angst J., Gamma A., Benazzi F., Ajdacic V., Eich D., and Rossler W. Diagnostic issues in bipolar disorder. Eur. Neuropsychopharmacol. 2 13 Suppl (2003) S43-50
5. Angst J., Gamma A., and Lewinsohn P. The evolving epidemiology of bipolar disorder. World Psychiatry 1 (2002) 146-148
6. Arinami T., Yamada N., Yamakawa-Kobayashi K., Hamaguchi H., and Toru M. Methylenetetrahydrofolate reductase variant and schizophrenia/depression. Am. J. Med. Genet. B Neuropsychiatr. Genet. 74 (1997) 526-528
7. Bauer M., and Pfennig A. Epidemiology of bipolar disorders. Epilepsia 4 46 Suppl (2005) 8-13
8. Baum A.E., Akula N., Cabanero M., Cardona I., Corona W., Klemens B., Schulze T.G., Cichon S., Rietschel M., Nothen M.M., Georgi A., Schumacher J., Schwarz M., Abou Jamra R., Hofels S., Propping P., Satagopan J., Detera-Wadleigh S.D., Hardy J., and McMahon F.J. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol. Psychiatry 13 (2008) 197-207
9. Bottiglieri T. Folate, vitamin B12, and neuropsychiatric disorders. Nutr. Rev. 54 (1996) 382-390
10. Brattstrom L., Wilcken D.E., Ohrvik J., and Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation 98 (1998) 2520-2526
11. Freeman J.M., Finkelstein J.D., and Mudd S.H. Folate-responsive homocystinuria and "schizophrenia". A defect in methylation due to deficient 5,10-methylenetetrahydrofolate reductase activity. N. Engl. J. Med. 292 (1975) 491-496
12. Friso S., Choi S.W., Girelli D., Mason J.B., Dolnikowski G.G., Bagley P.J., Olivieri O., Jacques P.F., Rosenberg I.H., Corrocher R., and Selhub J. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 5606-5611
13. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J.H., den Heijer M., Kluijtmans L.A.J., van den Heuve L.P., and Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10 (1995) 111-113
14. Greene J.G. Gene expression profiles of brain dopamine neurons and relevance to neuropsychiatric disease. J. physiol. 575 (2006) 411-416
15. Hahn L.W., Ritchie M.D., and Moore J.H. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 19 (2003) 376-382
16. Jacques P.F., Bostom A.G., Williams R.R., Ellison R.C., Eckfeldt J.H., Rosenberg I.H., Selhub J., and Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93 (1996) 7-9
17. Jonsson E.G., Larsson K., Vares M., Hansen T., Wang A.G., Djurovic S., Ronningen K.S., Andreassen O.A., Agartz I., Werge T., Terenius L., and Hall H. Two methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms, schizophrenia and bipolar disorder: an association study. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147 (2008) 976-982
18. Kempisty B., Mostowska A., Gorska I., Luczak M., Czerski P., Szczepankiewicz A., Hauser J., and Jagodzinski P.P. Association of 677C > T polymorphism of methylenetetrahydrofolate reductase (MTHFR) gene with bipolar disorder and schizophrenia. Neurosci. Lett. 400 (2006) 267-271
19. Kempisty B., Sikora J., Lianeri M., Szczepankiewicz A., Czerski P., Hauser J., and Jagodzinski P.P. MTHFD 1958G >A and MTR 2756A>G polymorphisms are associated with bipolar disorder and schizophrenia. Psychiatr. Genet. 17 (2007) 177-181
20. Kunugi H., Fukuda R., Hattori M., Kato T., Tatsumi M., Sakai T., Hirose T., and Nanko S. C677T polymorphism in methylenetetrahydrofolate reductase gene and psychoses. Mol. Psychiatry 3 (1998) 435-437
21. Lee E.S., Chen H., Soliman K.F., and Charlton C.G. Effects of homocysteine on the dopaminergic system and behavior in rodents. Neurotoxicology 26 (2005) 361-371
22. Reif A., Pfuhlmann B., and Lesch K.P. Homocysteinemia as well as methylenetetrahydrofolate reductase polymorphism are associated with affective psychoses. Prog. Neuropsychopharmacol. Biol. Psychiatry 29 (2005) 1162-1168
23. Reutens S., and Sachdev P. Homocysteine in neuropsychiatric disorders of the elderly. Int. J. Geriatr. Psychiatry 17 (2002) 859-864
24. Reynolds E.H., and Stramentinoli G. Folic acid, S-adenosylmethionine and affective disorder. Psychol. Med. 13 (1983) 705-710
25. Rouillon F. Epidemiology of bipolar disorders, Current studies. Encephale 23 (1997) 7-11 Spec no. 1
26. Shi Y.Y., and He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 15 (2005) 97-98
27. Shih R.A., Belmonte P.L., and Zandi P.P. A review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disorders,. Int. rev. psychiatry (Abingdon England) 16 (2004) 260-283
28. Stern L.L., Mason J.B., Selhub J., and Choi S.W. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol. Biomarkers Prev. 9 (2000) 849-853
29. Tan E.C., Chong S.A., Lim L.C., Chan A.O., Teo Y.Y., Tan C.H., and Mahendran R. Genetic analysis of the thermolabile methylenetetrahydrofolate reductase variant in schizophrenia and mood disorders. Psychiatr. Genet. 14 (2004) 227-231
30. van Vliet J., Oates N.A., and Whitelaw E. Epigenetic mechanisms in the context of complex diseases. Cell Mol. Life Sci. 64 (2007) 1531-1538